Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Legendre

Showing results (271-280 of 309) with videos related to

Pageof 31
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 21, 2010
Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level?G Canaud, B Knebelmann, P C Harris, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 19, 2008
Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantationM Le Quintrec, A Lionet, N Kamar, et al.
La Revue De Medecine Interne|January 13, 2006
[Sirolimus-associated interstitial pneumonitis in a renal transplant patient]C Bauer, O Lidove, C Lamotte, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 10, 2018
Propensity score-based comparison of the graft failure risk between kidney transplant recipients of standard and expanded criteria donor grafts: Toward increasing the pool of marginal donorsA H Querard, F Le Borgne, A Dion, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2013
Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changesG Canaud, N Kamar, D Anglicheau, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 2, 2010
Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodiesG Canaud, F Bienaimé, L-H Noël, et al.
Transplantation|October 17, 2001
A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipientsC Ponticelli, A Yussim, V Cambi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2008
A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donorsD Anglicheau, A Loupy, C Lefaucheur, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 21, 2010
High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF StudyF Martinez, N Kamar, N Pallet, et al.
Clinical Pharmacology and Therapeutics|October 2, 2009
Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatientsE Pautas, C Moreau, I Gouin-Thibault, et al.
Pageof 31

Showing results (271-280 of 309) with videos related to

Sort By:
Pageof 31
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 21, 2010
Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level?G Canaud, B Knebelmann, P C Harris, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 19, 2008
Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantationM Le Quintrec, A Lionet, N Kamar, et al.
La Revue De Medecine Interne|January 13, 2006
[Sirolimus-associated interstitial pneumonitis in a renal transplant patient]C Bauer, O Lidove, C Lamotte, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 10, 2018
Propensity score-based comparison of the graft failure risk between kidney transplant recipients of standard and expanded criteria donor grafts: Toward increasing the pool of marginal donorsA H Querard, F Le Borgne, A Dion, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2013
Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changesG Canaud, N Kamar, D Anglicheau, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 2, 2010
Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodiesG Canaud, F Bienaimé, L-H Noël, et al.
Transplantation|October 17, 2001
A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipientsC Ponticelli, A Yussim, V Cambi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2008
A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donorsD Anglicheau, A Loupy, C Lefaucheur, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 21, 2010
High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF StudyF Martinez, N Kamar, N Pallet, et al.
Clinical Pharmacology and Therapeutics|October 2, 2009
Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatientsE Pautas, C Moreau, I Gouin-Thibault, et al.
Pageof 31